Charles River Laboratories International Aktie
156,70
EUR
+6,95
EUR
+4,64
%
183,96
USD
+7,17
USD
+4,05
%
Werbung
Charles River Laboratories International Aktie Analyse
| 06.09.16 | Charles River Laboratories International Sell | UBS AG | |
| 20.05.16 | Charles River Laboratories International Underweight | Barclays Capital | |
| 10.07.15 | Charles River Laboratories International Underweight | Barclays Capital |
Werbung
Werbung